Brilinta Launch Website Sep 20, 2015Sep 22, 2015 Brand: Brilinta (ticagrelor), Tablets Parent Company: AstraZeneca Drug Type: Boxed Warning Drug Category: Cardiovascular Campaign: Launch Targeting: HCPs, Patients, Caregivers Patient Website: https://www.brilinta.com/ HCP Website: https://www.brilintatouchpoints.com/ Patient Homepage Patient Level 2 Page HCP Homepage HCP Level 2 Page